Skip to main content
. Author manuscript; available in PMC: 2016 Apr 28.
Published in final edited form as: J Am Coll Cardiol. 2015 Apr 28;65(16):1668–1682. doi: 10.1016/j.jacc.2015.03.043

Table 1.

Summary of HFpEF Diagnosis Guidelines

Guidelines Diagnosis
ESC (9) The following 4 criteria are required: 1) symptoms typical of HF; 2) signs typical of HF; 3) normal or
only mildly reduced LVEF and LV not dilated; and 4) relevant structural heart disease (LV
hypertrophy/LA enlargement) and/or diastolic dysfunction
ACC/AHA–HFpEF
(6)
Diastolic HF. Multiple criteria have been used; exclude other potential noncardiac causes of symptoms
suggestive of HF.
ACC/AHA–EF
41%-49%
Borderline or intermediate EF; these patients have similar characteristics, treatment patterns, and
outcomes to those with HFpEF
ACC/AHA–
improved EF
Patients previously with HFrEF; improved or recovered EF clinically distinct from patients with
preserved or reduced EF.
HFSA (7) Patients with EF ≥50% with symptoms suggestive of HF. Use echocardiography, ECG, stress imaging, or
cardiac catheterization to distinguish HF with preserved LVEF and other cardiac disorders.

ACC = American College of Cardiology; AHA = American Heart Association; ECG = electrocardiogram; ESC = indicates European Society of Cardiology; HF = heart failure; HFpEF = heart failure with preserved ejection fraction; HFrEF = heart failure with reduced ejection fraction; HFSA = Heart Failure Society of America LA = left atrial; LV = left ventricle; LVEF = left ventricular ejection fraction.

HHS Vulnerability Disclosure